ALKBH3 and lung carcinoma: ALKBH3 gene silencing inhibits cancer cell survival, and targeted downregulation, as was carried out in our in vivo study by injection of a siRNA and atelocollagen cocktail, could be a novel clinical tool for lung cancer therapy.